Prosoma
Digital mental health support for cancer patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | N/A | Series A | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | - | 46 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Prosoma is a digital health company that develops certified medical applications to provide mental health support and behavioral therapy for cancer patients. Founded in 2017 by Marek Ostrowski and Emanuela Kufel, and officially established in 2018, the company is dedicated to improving the quality of life for individuals undergoing cancer treatment. Marek Ostrowski, a psycho-oncologist and serial entrepreneur, provides the driving vision, while Emanuela Kufel brings experience in healthcare communications. The team also includes co-founders Andrzej Jonczyk and Piotr Grudzinski.
The company's core product is "Living Well," a Class I medical device and self-care mobile application that delivers a clinically validated, personalized therapeutic program. This program is designed to help patients manage symptoms of stress, anxiety, and depression related to their diagnosis and treatment. The app includes interactive educational content, relaxation exercises, and tools based on Cognitive Behavioral Therapy (CBT) and mindfulness to help users build healthy habits. Prosoma's platform is designed for a range of users, including patients, physicians, healthcare providers, and pharmaceutical companies. The business model focuses on making the digital therapy prescribable by doctors and reimbursable by healthcare systems. The "Living Well" app is already reimbursed by some statutory health insurance providers in Germany.
Prosoma has secured multiple rounds of funding, including a Pre-Series A round of €4.4 million, to scale its operations in the DACH region (Germany, Austria, Switzerland) and expand into the U.S. market. The company collaborates with an interdisciplinary team of scientists, psychologists, and engineers to ensure its products meet the highest clinical, technical, and data security standards, including GDPR, ISO 13485, and ISO/IEC 27001.
Keywords: digital therapeutics, oncology, psycho-oncology, mental health support, cancer care, behavioral therapy, health-tech, medical application, digital health, cancer patients, stress reduction, anxiety management, depression support, Living Well app, CE certified medical device, personalized therapy, cognitive behavioral therapy, mobile health, self-care solution, patient-centered care